P2.03a-014 A Dose-Finding and Phase 2 Study of Ruxolitinib plus Pemetrexed/Cisplatin for Nonsquamous Non–Small Cell Lung Cancer (NSCLC): Topic: Clinical Trials
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology January 2017 12(1) Supplement:S895-S896 - Subject
- Language
- ISSN
- 1556-0864